Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy And Safety Of Eraxis/Ecalta (Anidulafungin) Compared To Cancidas (Caspofungin) In Patients With Candida Deep Tissue Infection

NCT00805740 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00805740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy And Safety Of Eraxis/Ecalta (Anidulafungin) Compared To Cancidas (Caspofungin) In Patients With Candida Deep Tissue Infection
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2009
Completion date
June 30, 2012
Enrollment
41 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis, fungemia